MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers and First Responders
Nautilus Sanctuary
View at source ↗Clinical trial
Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.
Brief summary
The purpose of this study is to assess the safety and efficacy of MDMA-Assisted Therapy on Frontline Health Care Workers and First Responders suffering from symptoms of Post-Traumatic Stress.
Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.
Trial details
- status
- NOT_YET_RECRUITING
- phase
- PHASE2
- study type
- INTERVENTIONAL
- enrollment
- 30
- sponsor
- Nautilus Sanctuary
- conditions
- Post-Traumatic Stress Disorder; Adjustment Disorders
- interventions
- DRUG: MDMA
- start date
- 2026-10-01
- start date type
- ESTIMATED
- primary completion date
- 2028-01-01
- has results
- false
- data source
- ClinicalTrials.gov
- data processed
- 2026-10-29T09:00:05
- modifications
- selected fields only; whitespace normalized; brief summary truncated to 2,000 characters
Record
- Archive ID
- nct:NCT05455996
- Published
- Jul 13, 2022
- Updated
- May 5, 2026
- Venue
- ClinicalTrials.gov
- ClinicalTrials.gov
- NCT05455996
- Categories
- Post-Traumatic Stress Disorder, Adjustment Disorders
- License
- ClinicalTrials.gov terms (attribution, processing date, modifications noted)
- Provenance
- clinicaltrials